Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment
Get your vitamin D levels checked Vitamin D has been reclassified as a steroid hormone and a vitamin because it works directly with the endocrine system
Some doctors prescribe a vitamin B12 shot regularly, which they can give you in the office or teach you to do it yourself at home
A message from ANZOS: We do not endorse diet products: It has come to our attention that a company is fraudulently using the ANZOS logo to promote an unregulated Moringa-based supplement falsely marketed as a GLP-1 alternative
On phase: 3 months of active dosing per cycle
The result is skin that feels more stable, looks more refreshed, and fits into a routine you dont have to second-guess